CHI3L1 and pancreatic adenocarcinoma: The aim of their study was to evaluate the effect of anti-YKL-40 monoclonal antibody on tumor growth and morphology in xenograft model of human melanoma, as well as pancreatic adenocarcinoma in scid mice.